PREDICTIVE VALUE OF CARDIAC CACHEXIA IN CHRONIC HEART FAILURE
Regardless current achievements of medicine, chronic heart failure (CHF) is still the leading cause of cardiovascular morbidity and mortality. A special cohort in CHF mortality are patients with progressive body mass loss. Recently the assessment of cachexia is restricted only...
Saved in:
| Main Authors: | E. S. Drobysheva, R. E. Tokmachev, A. V. Budnevsky, A. Ya. Kravchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2016-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/374 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ghrelin peptide in heart failure: when is showtime?
by: Som P. Singh, et al.
Published: (2025-07-01) -
Prognostic Impact and Prevalence of Cachexia in Patients With Heart Failure: A Systematic Review and Meta‐Analysis
by: Konstantinos Prokopidis, et al.
Published: (2024-12-01) -
Comorbidity of chronic heart failure and chronic obstructive pulmonary disease: features of pathogenesis, clinic and diagnostics
by: R. E. Tokmachev, et al.
Published: (2018-12-01) -
Biomarkers ST2 and interleukin 33 for assessing the severity of cardiac inflammation and fibrosis in patients with chronic heart failure
by: O. M. Drapkina, et al.
Published: (2021-10-01) -
Features of cardiac remodeling and GDF 15 and NTproBNP levels in patients with heart failure and preserved ejection fraction depending on the history of myocardial infarction
by: Ya. V. Zemlianyi, et al.
Published: (2024-10-01)